Dobutamine and Carbidopa/Levodopa Interaction
Drug interaction information between Dobutamine and Carbidopa/Levodopa.
Dobutamine and Carbidopa/Levodopa have a documented moderate interaction in FDA labeling.
FDA drug labeling documents a moderate-severity interaction between Dobutamine and Carbidopa/Levodopa. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
These drugs are broken down by the same enzyme, so taking them at the same time can lead to higher drug levels. This can cause dangerous changes in blood pressure or an irregular heartbeat.
What To Do
Your doctor should use caution when giving these drugs together. They will likely monitor your heart rhythm and blood pressure for any problems.
FDA Label Information
7.2 Drugs Metabolized by Catechol-O-Methyltransferase (COMT) Drugs known to be metabolized by COMT, such as isoproterenol, epinephrine, norepinephrine, dopamine, dobutamine, alpha-methyldopa, apomorphine, isoetherine, and bitolterol should be administered with caution in patients receiving entacapone regardless of the route of administration (including inhalation), as their interaction may result in increased heart rates, possibly arrhythmias, and excessive changes in blood pressure [ see Warnings and Precautions (5.10) ].
Dobutamine Also Interacts With
- Atomoxetine minor
- Propranolol minor
Carbidopa/Levodopa Also Interacts With
- Warfarin moderate
- Entacapone moderate
- Methyldopa moderate
- Dopamine moderate
- Epinephrine moderate
Frequently Asked Questions
Can I take Dobutamine and Carbidopa/Levodopa together?
This is a moderate interaction. Your doctor should use caution when giving these drugs together. They will likely monitor your heart rhythm and blood pressure for any problems.
How serious is the interaction between Dobutamine and Carbidopa/Levodopa?
This interaction is classified as "moderate" severity by the FDA. Moderate interactions may worsen your condition or change how your medications work.
Why do Dobutamine and Carbidopa/Levodopa interact?
These drugs are broken down by the same enzyme, so taking them at the same time can lead to higher drug levels. This can cause dangerous changes in blood pressure or an irregular heartbeat.
Understanding the Dobutamine and Carbidopa/Levodopa Interaction
FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Dobutamine belongs to the Inotropic Agent (Beta-1 Agonist) class and Carbidopa/Levodopa belongs to the Dopamine Precursor Combination class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: These drugs are broken down by the same enzyme, so taking them at the same time can lead to higher drug levels. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Dobutamine has 3 total documented interactions on file in this dataset, and Carbidopa/Levodopa has 13. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor should use caution when giving these drugs together. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Dobutamine or Carbidopa/Levodopa based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.